TERLIVAZ TERLIPRESSIN FOR INJECTION Trademark

Trademark Overview

On Thursday, February 12, 2015, a trademark application was filed for TERLIVAZ TERLIPRESSIN FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the TERLIVAZ TERLIPRESSIN FOR INJECTION trademark a serial number of 86532781. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 22, 2018. This trademark is owned by Ikaria Therapeutics LLC. The TERLIVAZ TERLIPRESSIN FOR INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of hepatorenal syndrome, also known as HRS, containing terlipressin
terlivaz terlipressin for injection

General Information

Serial Number86532781
Word MarkTERLIVAZ TERLIPRESSIN FOR INJECTION
Filing DateThursday, February 12, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 22, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Description of MarkThe mark consists of the stylized term "TERLIVAZ" with a capital "T" and the smaller, lowercase words "TERLIPRESSIN FOR INJECTION" beneath it. "TERLIPRESSIN" is bolder in tone than the remaining words. Above "TERLIVAZ" is a two-toned brush stroke that begins at a point above the capital "T" in "TERLIVAZ" and which grows in size, curving down and concluding above the "Z" in "TERLIVAZ".
Goods and Servicespharmaceutical preparations for the treatment of hepatorenal syndrome, also known as HRS, containing terlipressin
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"TERLIPRESSIN FOR INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIkaria Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHampton, NJ 088279001
Party NameIkaria Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHampton, NJ 088279001

Trademark Events

Event DateEvent Description
Wednesday, November 22, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 22, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 22, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2018SOU EXTENSION 5 GRANTED
Wednesday, February 28, 2018SOU EXTENSION 5 FILED
Friday, March 2, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 28, 2018SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2017SOU EXTENSION 4 GRANTED
Tuesday, September 12, 2017SOU EXTENSION 4 FILED
Tuesday, September 12, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2017SOU EXTENSION 3 GRANTED
Monday, March 6, 2017SOU EXTENSION 3 FILED
Monday, March 6, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, September 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2016SOU EXTENSION 2 GRANTED
Thursday, September 1, 2016SOU EXTENSION 2 FILED
Tuesday, September 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 1, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2016SOU EXTENSION 1 GRANTED
Friday, March 11, 2016SOU EXTENSION 1 FILED
Friday, March 11, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 13, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 12, 2015ASSIGNED TO LIE
Tuesday, May 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 23, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 22, 2015NON-FINAL ACTION E-MAILED
Friday, May 22, 2015NON-FINAL ACTION WRITTEN
Friday, May 22, 2015NON-FINAL ACTION WRITTEN
Wednesday, May 20, 2015ASSIGNED TO EXAMINER
Saturday, February 28, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 16, 2015NEW APPLICATION ENTERED

Related Keywords

injection terlipressin terlivaz known containing also syndrome preparations treatment hepatorenal pharmaceutical